Article
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Jun 2009
Perlis Roy H, Laje Gonzalo, Smoller Jordan W, Fava Maurizio, Rush A John, McMahon Francis J
Abstract excerpt
Sexual dysfunction is a major contributor to treatment discontinuation and nonadherence among patients treated with selective serotonin reuptake inhibitors (SSRIs). The mechanisms by which depressive symptoms in general, as well as SSRI exposure in particular, may worsen sexual function are not known. We examined genetic polymorphisms, including those of the serotonin and glutamate systems, for association with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
